Cargando…

The risk of type 2 oral polio vaccine use in post-cessation outbreak response

BACKGROUND: Wild type 2 poliovirus was last observed in 1999. The Sabin-strain oral polio vaccine type 2 (OPV2) was critical to eradication, but it is known to revert to a neurovirulent phenotype, causing vaccine-associated paralytic poliomyelitis. OPV2 is also transmissible and can establish circul...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCarthy, Kevin A., Chabot-Couture, Guillaume, Famulare, Michael, Lyons, Hil M., Mercer, Laina D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627419/ https://www.ncbi.nlm.nih.gov/pubmed/28974220 http://dx.doi.org/10.1186/s12916-017-0937-y

Ejemplares similares

Assessing the stability of polio eradication after the withdrawal of oral polio vaccine
por: Famulare, Michael, et al.
Publicado: (2018)

Assessing the sensitivity of the polio environmental surveillance system
por: Kroiss, Steve J., et al.
Publicado: (2018)

Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria
por: Upfill-Brown, Alexander M., et al.
Publicado: (2016)

Measuring polio immunity to plan immunization activities
por: Voorman, Arend, et al.
Publicado: (2016)

Disease Surveillance Investments and Administration: Limits to Information Value in Pakistan Polio Eradication
por: Scott, Ryan P., et al.
Publicado: (2020)

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study
por: Taniuchi, Mami, et al.
Publicado: (2017)

A spatial model of Wild Poliovirus Type 1 in Kano State, Nigeria: calibration and assessment of elimination probability
por: McCarthy, Kevin A., et al.
Publicado: (2016)

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
por: Zhao, Ting, et al.
Publicado: (2021)

Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan
por: Voorman, Arie, et al.
Publicado: (2020)

Environmental Surveillance of Polioviruses in Armenia, Colombia before Trivalent Oral Polio Vaccine Cessation
por: González, María Mercedes, et al.
Publicado: (2019)

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
por: Wahid, Rahnuma, et al.
Publicado: (2021)

Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
por: Martini Rodrigues, Camila Cristina, et al.
Publicado: (2022)

Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in Pakistan
por: Mercer, Laina D., et al.
Publicado: (2017)

Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine
por: Jarvis, Christopher I, et al.
Publicado: (2018)

Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch in Indonesia
por: Holmes, Marionette, et al.
Publicado: (2017)

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
por: Tevi-Benissan, Carol, et al.
Publicado: (2017)

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
por: Hampton, Lee M., et al.
Publicado: (2017)

Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region
por: Fahmy, Kamal, et al.
Publicado: (2017)

Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame
por: Gaensbauer, James T, et al.
Publicado: (2018)

The 2022 Malawi Polio outbreak
por: Chunda, Penjani, et al.
Publicado: (2022)

Polio outbreak response, Yemen
por: Beshr, Ibrahem Abduallah, et al.
Publicado: (2023)

Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals
por: Thomassen, Yvonne E., et al.
Publicado: (2013)

Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine
por: Wanyoike, Sarah, et al.
Publicado: (2017)

Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence
por: Yagovkina, Nadezhda V., et al.
Publicado: (2022)

Circulating vaccine derived polio virus type 1 outbreak, Saadah governorate, Yemen, 2020
por: Al-Qassimi, Mutahar Ahmed, et al.
Publicado: (2022)

Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study
por: Sørup, Signe, et al.
Publicado: (2015)

Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies
por: Pan, William K., et al.
Publicado: (2019)

1990. Evaluating the Impact of Directed Provider Outreach Urging Polio Vaccination During a Polio Outbreak – Rockland County New York, 2022
por: Masters, Nina B, et al.
Publicado: (2023)

Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies()
por: Voorman, Arend, et al.
Publicado: (2023)

Assessing and Mitigating the Risks for Polio Outbreaks in Polio-Free Countries — Africa, 2013–2014
por: Andre, McKenzie, et al.
Publicado: (2014)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
por: Marsian, Johanna, et al.
Publicado: (2017)

Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria
por: Upfill-Brown, Alexander M, et al.
Publicado: (2014)

Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (DOPV) in northern Nigeria, (2014–2016)
por: Korir, Charles, et al.
Publicado: (2018)

Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Use of oral polio vaccine and the incidence of COVID-19 in the world
por: Habibzadeh, Farrokh, et al.
Publicado: (2022)

Protecting Australia from Future Polio Outbreaks
por: Paterson, Beverley J., et al.
Publicado: (2015)

Post-Polio Syndrome Revisited
por: Punsoni, Michael, et al.
Publicado: (2023)

Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles–rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh
por: Khan, Ashraful Islam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7d1fru0j2c50ndebf2ra3v49un